Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells. (4th November 2015) - Ruella, Marco; Barrett, David M; Kenderian, Saad S; Shestova, Olga; Hofmann, Ted J; Scholler, John; Lacey, Simon F; Melenhorst, Jan J; Nazimuddin, Farzana; Perazzelli, Jessica; Christian, David A; Hunter, Christopher A; et al.